George Davis, CEO of the Maryland Technology Development Corporation (TEDCO), joins Rich Bendis to discuss the Economic Development Balance, Goals for Business in the State, and the Partnership across the Region.
The grants came through the National Institute of Allergy and Infectious Diseases and the National Science Foundation.
Precision Medicine Group announced it had raised $275 million. The round was led by Berkshire Partners and TPG Growth, with participation from its co-founders and management team, as well as original investors Oak Investment Partners and J.H. Whitney.
Global pharmaceutical company Mallinckrodt Plc (NYSE: MNK) has entered an agreement to buy Rockville’s Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP) for $1.2 billion including debt.
Ashish K. Kulkami, PhD of Avantor, Anne S. Lindblad, PhD of The Emmes Corporation, and Kurt Newman, MD of Children’s National Health System, Join BHI’s Board
BioHealth Innovation, Inc. (BHI) announced that its Board of Directors has unanimously approved the appointments of three new board members, Ashish K. Kulkarni, PhD, Executive Vice President and Chief Technology Officer of Avantor, Anne S. Lindblad, PhD, President and CEO, The Emmes Corporation, and Kurt Newman, MD, President and Chief Executive Officer, Children’s National Health System.
University of Maryland, Baltimore startup Harpoon Medical was acquired by Edwards Lifesciences for $100 million, Edwards announced Wednesday. The deal could rise to $150 million if Harpoon meets pre-specified milestones.
AN INTERVIEW WITH GSK’S CHRISTOPHER MADDOX, DIRECTOR OF SITE OPERATIONS
MOCONNECT recently interviewed GSK’s Christopher Maddox, Director of Site Operations for The Slaoui Center for Vaccines Research in Rockville. The company made news when it selected Rockville to serve as its U.S. R&D Center, furthering strengthening Montgomery County as a major player in global healthcare.
Five startups have been selected to participate in the inaugural M-1 Ventures health and fitness-focused accelerator program based at Johns Hopkins University.
Women Building Bio: the XX factor is a day long conference to recognize and learn from leading women in the bioscience industry as pioneers paving the path to success. These women have faced their own unique challenges and carved out lasting legacies.
This day will catalyze the formation of a diverse network. It is a convergence of academia and industry, men and women, researchers and innovators, professionals and decision-makers gathering together to build relationships. This day long conference provides extraordinary opportunities to exchange new ideas, highlight areas of bioscience and research opportunities, and find partners for future collaboration.
TEDCO’s 7th Annual Entrepreneur Expo will bring together all of Maryland’s entrepreneurial resources from across the state into one place, at one time.
You can expect to see 700+ of the region’s top entrepreneurs, small and large business executives, angel and venture capital investors, federal and state economic development officials, university leaders and legislators.